Beadle Beth M, Shoichet Brian K
Department of Molecular Pharmacology and Biological Chemistry, Northwestern University School of Medicine, 303 East Chicago Avenue S215, Chicago, IL 60611-3008, USA.
J Mol Biol. 2002 Aug 9;321(2):285-96. doi: 10.1016/s0022-2836(02)00599-5.
The structures of enzymes reflect two tendencies that appear opposed. On one hand, they fold into compact, stable structures; on the other hand, they bind a ligand and catalyze a reaction. To be stable, enzymes fold to maximize favorable interactions, forming a tightly packed hydrophobic core, exposing hydrophilic groups, and optimizing intramolecular hydrogen-bonding. To be functional, enzymes carve out an active site for ligand binding, exposing hydrophobic surface area, clustering like charges, and providing unfulfilled hydrogen bond donors and acceptors. Using AmpC beta-lactamase, an enzyme that is well-characterized structurally and mechanistically, the relationship between enzyme stability and function was investigated by substituting key active-site residues and measuring the changes in stability and activity. Substitutions of catalytic residues Ser64, Lys67, Tyr150, Asn152, and Lys315 decrease the activity of the enzyme by 10(3)-10(5)-fold compared to wild-type. Concomitantly, many of these substitutions increase the stability of the enzyme significantly, by up to 4.7kcal/mol. To determine the structural origins of stabilization, the crystal structures of four mutant enzymes were determined to between 1.90A and 1.50A resolution. These structures revealed several mechanisms by which stability was increased, including mimicry of the substrate by the substituted residue (S64D), relief of steric strain (S64G), relief of electrostatic strain (K67Q), and improved polar complementarity (N152H). These results suggest that the preorganization of functionality characteristic of active sites has come at a considerable cost to enzyme stability. In proteins of unknown function, the presence of such destabilized regions may indicate the presence of a binding site.
酶的结构反映出两种看似相互对立的倾向。一方面,它们折叠成紧密、稳定的结构;另一方面,它们结合配体并催化反应。为了保持稳定,酶通过折叠使有利的相互作用最大化,形成紧密堆积的疏水核心,暴露亲水基团,并优化分子内氢键。为了发挥功能,酶开辟出一个用于配体结合的活性位点,暴露疏水表面积,聚集同类电荷,并提供未满足的氢键供体和受体。利用结构和机制都已得到充分表征的AmpCβ-内酰胺酶,通过替换关键活性位点残基并测量稳定性和活性的变化,研究了酶稳定性与功能之间的关系。与野生型相比,催化残基Ser64、Lys67、Tyr150、Asn152和Lys315的替换使酶的活性降低了10³-10⁵倍。与此同时,许多此类替换显著提高了酶的稳定性,最高可达4.7千卡/摩尔。为了确定稳定化的结构起源,测定了四种突变酶的晶体结构,分辨率在1.90埃至1.50埃之间。这些结构揭示了几种提高稳定性的机制,包括被取代残基对底物的模拟(S64D)、空间应变的缓解(S64G)、静电应变的缓解(K67Q)以及极性互补性的改善(N152H)。这些结果表明,活性位点特有的功能预组织是以酶稳定性的显著代价实现的。在功能未知的蛋白质中,此类不稳定区域的存在可能表明存在一个结合位点。